Company: SNY
Filing Date: 2025-11-03
Form Type: 6-K
Source: 0001193125-25-262033
Chunk: 0

Company: Sanofi
Filing Date: 2025-11-03
Form: 6-K
Chunk 0
---
### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

November 3, 2025

Commission File Number: 001-31368

### SANOFI
(Translation of registrant’s name into English)

46, avenue de la Grande Armée, 75017 Paris, France

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

THIS REPORT ON FORM 6-KSHALL BE DEEMED TO BE INCORPORATED BY REFERENCE IN THE REGISTRATION STATEMENT ON FORM F-3FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON APRIL 4, 2024 (NO. 333-278506)AND TO BE PART THEREOF FROM THE DATE ON WHICH THIS REPORT IS FURNISHED, TO THE EXTENT NOT SUPERSEDED BY DOCUMENTS OR REPORTS SUBSEQUENTLY FILED OR FURNISHED BY SANOFI.

On November 3, 2025, Sanofi issued $500,000,000 principal amount of floating rate notes due November 3, 2027, $500,000,000 principal amount of floating rate notes due November 3, 2028, $400,000,000 principal amount of fixed rate notes due November 3, 2027, $400,000,000 principal amount of fixed rate notes due November 3, 2028 and $1,200,000,000 principal amount of fixed rate notes due November 3, 2032. The following documents related thereto, attached hereto as Exhibits 1.1, 4.1, 4.2, 4.3, 4.4, 4.5, 4.6, 5.1 and 5.2 are incorporated herein by reference. Exhibit List

| Exhibit      
 No.          
 Exhibit 1.1  
 Exhibit 4.1  |     | Description                                                                                                                                                      
 Underwriting Agreement dated October                                                                                                                             
 27, 2025, by and among Sanofi and each of Barclays Capital Inc., BNP Paribas